Answers are grounded in this paper and cite their sources.
This investigation reveals cytokine correlations with IEC-HS severity in those receiving CAR T cells, suggesting preemptive strategies.
Summary: Immune effector cell–associated hemophagocytic lymphohistiocytosis–like syndrome (IEC-HS) is a complication seen in patients receiving chimeric antigen receptor (CAR) T cells, more frequently in those with CD22- or BCMA-targeted constructs compared with CD19. While associated with higher CAR T-cell expansion and a unique cytokine profile, the constellation of three cytokines (IFNγ, IL10, and IL1RA) correlated most strongly with IEC-HS severity and may help guide preemptive interventions. See related article by Srinagesh et al., p. XX .
No takes yet. Share an insight, caveat, or question.
Rocco et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: